← Back to Search

Robotics

My Special Aflac Duck (MSAD) for Pediatric Cancer (MSAD Trial)

N/A
Waitlist Available
Led By Tamara Miller, MD, MSCE
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 1, month 1, month 3
Awards & highlights

MSAD Trial Summary

This trial will test whether the use of a toy robot, the My Special Aflac Duck, can help to relieve stress in children who have cancer.

MSAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 1, month 1, month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 1, month 1, month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Parent Reported Patient Distress with Distress Thermometer
Secondary outcome measures
Change Parent Reported in PedsQL - Cancer Module Score
Change in Brief Symptom Inventory 18 (BSI-18) Score
Change in Child Life Specialist Reported CTCAE - Depression Score
+18 more

MSAD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MSAD InterventionExperimental Treatment1 Intervention
Children receiving cancer treatment in a hospital randomized to the My Special Aflac Duck (MSAD) intervention.
Group II: Control GroupActive Control1 Intervention
Children receiving cancer treatment in a hospital randomized to be a control hospital. Children in the control hospitals will receive the My Special Aflac Duck (MSAD) at the end of the intervention period.

Find a Location

Who is running the clinical trial?

American Family Life Assurance Company (Aflac Inc.)UNKNOWN
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,413 Total Patients Enrolled
Tamara Miller, MD, MSCEPrincipal Investigator - Emory University
Medical School - Emory University, Doctor of Medicine
University of South Carolina (Residency)
1 Previous Clinical Trials
118 Total Patients Enrolled

Media Library

My Special Aflac Duck (Robotics) Clinical Trial Eligibility Overview. Trial Name: NCT04409301 — N/A
Pediatric Cancer Research Study Groups: MSAD Intervention, Control Group
Pediatric Cancer Clinical Trial 2023: My Special Aflac Duck Highlights & Side Effects. Trial Name: NCT04409301 — N/A
My Special Aflac Duck (Robotics) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04409301 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation
Tamara Miller 2020. "Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04409301.
~35 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top